RedHill Biopharma Ltd. (RDHL) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear

RedHill Biopharma Ltd.

NASDAQ: RDHL · Real-Time Price · USD
1.90
-0.32 (-14.41%)
At close: Oct 03, 2025, 3:59 PM
1.95
2.63%
Pre-market: Oct 06, 2025, 07:00 AM EDT

RedHill Biopharma Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-1.85 0.79 -0.24 -2.46
PEG Ratio
0.02 -0.01 0.01 n/a
PS Ratio
1.90 2.90 0.28 2.80
PB Ratio
-3.27 9.14 -0.36 27.05
P/FCF Ratio
-1.63 -0.53 -0.59 -3.68
P/OCF Ratio
-1.63 -0.53 -0.6 -3.69
OCF/S Ratio
-1.16 -5.49 -0.47 -0.76
Debt / Equity Ratio
-0.08 0.57 -2.53 9.89
Quick Ratio
0.37 0.61 0.38 0.91
Current Ratio
0.54 0.84 0.44 1.09
Asset Turnover
0.45 0.28 0.39 0.47
Interest Coverage
-265.69 34.42 -1.04 -4.9
Return on Equity
1.77 11.56 1.48 -11.01
Return on Assets
-0.46 1.04 -0.45 -0.54
Return on Invested Capital
4.21 2.41 -0.55 -0.79
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.60 0.47 0.46 0.42
Net Profit Margin
-1.03 3.66 -1.16 -1.14
Pretax Profit Margin
-1.03 3.66 -1.16 -1.14
Operating Profit Margin
-1.82 1.93 -0.69 -0.95
FCF Margin
-1.17 -5.49 -0.48 -0.76
EBITDA Margin
-0.94 4.02 -0.36 -0.73